Private Wealth Management Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6K Hold
184
﹤0.01% 433
2026
Q1
$14.7K Buy
184
+120
+188% +$9.89K ﹤0.01% 412
2025
Q4
$5.46K Hold
64
﹤0.01% 739
2025
Q3
$4.98K Hold
64
﹤0.01% 795
2025
Q2
$5.01K Hold
64
﹤0.01% 760
2025
Q1
$4.64K Buy
64
+1
+2% +$72 ﹤0.01% 767
2024
Q4
$4.66K Hold
63
﹤0.01% 769
2024
Q3
$4.16K Sell
63
-107
-63% -$7.77K ﹤0.01% 802
2024
Q2
$15.7K Hold
170
0.01% 332
2024
Q1
$16.2K Hold
170
0.01% 312
2023
Q4
$13K Buy
+170
New +$11.8K 0.01% 353

Other funds holding EW

Private Wealth Management Group's EW Position: Q2 2026 in Review

Private Wealth Management Group held its Edwards Lifesciences (EW) position steady in Q2 2026 at 184 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Private Wealth Management Group first reported a position in EW in Q4 2023 and has held it in 11 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Private Wealth Management Group held 184 shares of Edwards Lifesciences worth $16.6K as of Q2 2026.
  • Private Wealth Management Group left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #433 holding.
  • Private Wealth Management Group first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.